Drug Shortage Report for RATIO-ATORVASTATIN

Last updated on 2017-10-10 History
Report ID 1803
Drug Identification Number 02350327
Brand name RATIO-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ATORVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-06-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-10-10 French Compare
v3 2017-10-10 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare